<DOC>
	<DOCNO>NCT00005118</DOCNO>
	<brief_summary>The purpose study see safe effective give indinavir plus ritonavir plus 2 NRTIs HIV-infected patient need early intervention treatment .</brief_summary>
	<brief_title>The Safety Effectiveness Indinavir Plus Ritonavir Plus Two NRTIs HIV-Infected Patients Who Need Early Intervention Treatment</brief_title>
	<detailed_description>Patients receive indinavir bid plus ritonavir bid , plus 2 NRTIs bid ( 2 new NRTIs 1 new NRTI 1 NRTI without evidence resistance ) . CD4 cell count plasma viral RNA measure every 4 week duration study . Physical examination laboratory test blood urine perform every 4 week duration study . Chest x-ray 12-lead ECG do prestudy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Are 18 year age old . Have CD4 cell count least 50 cells/mm3 . Have viral load ( level HIV blood ) least 400 copies/ml 20,000 copies/ml . Have initial response protease inhibitor therapy viral load le 400 copies/ml two consecutive test least 1 week apart . Have antiHIV ( antiretroviral ) treatment include indinavir nelfinavir least 16 week . Have virologic failure ( two consecutive viral load great equal 400 copies/ml less equal 20,000 copies/ml least 1 week apart ) due another infection , vaccination , temporary stop treatment . Are naive least one select NRTIs .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2001</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Indinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Nelfinavir</keyword>
</DOC>